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Abstract Apoptosis is initiated by activation of caspases
(interleukin 1L-converting enzyme homologues), which cause
coordinated cleavage of several death substrates that function in
structural or homeostatic pathways. The relationship between
substrate cleavage and apoptosis is not yet known, nor is it clear
whether cleavage of specific substrates is a critical requirement
for apoptosis. The human neutrophil provides novel insights into
the roles of proteolysis of specific substrates during apoptosis,
since only a subset of caspase substrates are present in mature
neutrophils. Of the death substrates we screened, PARP, the
nuclear mitotic apparatus protein (NuMA), the 70 kDa subunit
of the U1 small ribonucleoprotein (U1-70kDa) and the catalytic
subunit of DNA-dependent protein kinase (DNA-PKcs) were not
detected in non-apoptotic neutrophils ; in contrast, lamin B and
fodrin were present in amounts similar to those found in other
cells. Caspase-3 activity was absent in freshly isolated neutro-
phils, but was detected when neutrophils were aged in vitro,
coincident with the onset of morphologic and biochemical
apoptosis. The absence of PARP, NuMA, U1-70kDa and
DNA-PKcs in non-apoptotic neutrophils suggests that these are
not critical anti-apoptotic proteins, and that their fragments are
not required components of the neutrophil apoptotic pathway.
These studies highlight the conserved role of caspase activation in
the apoptotic mechanism, and focus attention on several
conserved structural substrates as potential transducers of the
proteolytic signal in apoptosis.
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1. Introduction
Activation of caspases is a critical component of the com-
mon execution pathway in apoptotic cells [1,2], likely by in-
ducing the speci¢c cleavage and functional alteration of key
downstream substrates [3,4]. In human cells, several substrates
for these proteases have been de¢ned including (i) enzymes
functioning in DNA repair pathways (e.g. PARP [5^7] and
DNA-PKcs [8,9]) ; (ii) proteins involved in homeostatic path-
ways (including D4-GDI [10], protein kinase C-N [11] and
sterol regulatory element binding proteins [12] ; and (iii) struc-
tural proteins including the nuclear lamins A and B [13], non-
erythroid spectrin (fodrin) [14^16], and the nuclear mitotic
apparatus protein (NuMA) [17,18]. However, the mechanisms
whereby cleavage of these substrates generates elements of the
apoptotic phenotype, and whether the generation of speci¢c
substrate fragments is critical in this regard, remain unknown
[3].
The human neutrophil is highly specialized for stimulus-
induced degranulation and oxygen burst, but as a terminally
di¡erentiated cell, it preserves only a truncated repertoire of
homeostatic pathways. Mature neutrophils undergo spontane-
ous apoptosis after isolation from blood [19^21]. To gain in-
sight into the nature of proteolysis during neutrophil apopto-
sis, we addressed whether substrates for the caspases are
present in these cells, and studied the kinetics and character-
istics of their cleavage during apoptosis. Our studies demon-
strate that mature neutrophils lack PARP, NuMA, U1-70kDa
and DNA-PKcs, indicating that fragments generated from
these molecules are unlikely to be critical mediators of the
apoptotic pathway in neutrophils. Several other caspase sub-
strates (e.g. fodrin and lamin B) are present in neutrophils in
amounts comparable to those found in HeLa cells, and are
cleaved during apoptosis. The data demonstrate that caspase-
mediated generation of speci¢c substrate fragments is not a
universal requirement during apoptosis of all cells. These data
further suggest that, in dividing cells capable of homeostasis,
caspases interrupt multiple homeostatic pathways by addi-
tively abolishing the function of several substrates.
2. Materials and methods
2.1. Isolation of neutrophils
Neutrophils (s 99% viable as assessed by trypan blue exclusion)
were isolated from fresh citrated normal human blood by dextran
sedimentation and Percoll (Pharmacia, Piscataway, NJ) density gra-
dient centrifugation as previously described [19,20]. Aging of neutro-
phils was performed in Iscove’s medium supplemented with 10% au-
tologous serum at 37‡C.
2.2. Fractionation of neutrophil contents and preparation of lysates
Fractionation for immunoblotting was performed as previously de-
scribed [22], with minor modi¢cations. Neutrophils were washed twice
in ice-cold phosphate bu¡ered saline, resuspended at 5U107 cells/ml
in relaxation bu¡er (10 mM PIPES pH 7.4, 100 mM KCl, 3.5 mM
MgCl2, 1.25 mM EGTA, 1 mM ATP supplemented with antipain,
pepstatin A, chymostatin, leupeptin, and PMSF), and incubated at
30 bar of nitrogen for 20 min in a cavitation bomb (Parr Instruments,
Moline, IL) on ice. Rapid depressurization produced almost total lysis
of cells, with preservation of multilobed nuclei. The crude lysate was
spun at 500Ug for 10 min, and the supernatant (‘cytosol fraction’)
was further spun at 14 000Ug for 5 min to remove contaminating
granules. Removal of granules from the cytosolic fraction was essen-
tial since their presence leads to non-speci¢c proteolysis, which de-
stroyed all substrates we investigated even when the sample was im-
mediately boiled in 2% SDS (data not shown). The pellet (‘nuclear
fraction’) was washed three times in relaxation bu¡er (500Ug for 10
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min), and resuspended in a volume equal to that of the cytosol. For
apoptosis reconstitution experiments, neutrophils were cavitated at 4^
8U108 cells/ml to achieve protein concentrations of 10^12 mg/ml. For
cleavage assays employing the £uorometric amino-4-methylcoumarin
tetrapeptide substrate Ac-DEVD-AMC, whole neutrophils were aged
for various times and then washed twice in PBS, resuspended in 10
mM PIPES pH 7.3, 10 mM KCl, 3 mM NaCl, 1.25 mM EGTA, and
3.5 mM MgCl2 with protease inhibitors, sonicated, and spun at
14 000Ug for 5 min to remove granules.
2.3. HeLa lysate preparation
Con£uent HeLa cells were harvested and lysed in bu¡er containing
1% Nonidet P-40, 20 mM Tris pH 7.4, 1 mM NaCl, 1 mM EDTA,
and protease inhibitors. Where indicated, apoptosis was induced by
irradiation with UVB as previously described [8,23].
2.4. Immunoblotting
Samples were electrophoresed on either 10% polyacrylamide gels
containing 0.087% bisacrylamide or 15% polyacrylamide gels contain-
ing 0.39% bisacrylamide, and transferred to nitrocellulose. Proteins
were immunoblotted with monospeci¢c patient sera recognizing
PARP, U1-70kDa, and NuMA, or monoclonal antibodies recognizing
DNA-PKcs (gift from T. Carter, St. Johns University, Jamaica, NY),
lamin B (Matritect, Cambridge, MA), actin (Sigma, St. Louis, MO),
and fodrin (Chemicon International, Temecule, CA), or rabbit poly-
clonal antibodies raised against caspase-3 (gift from Don Nicholson,
Merck Frosst, Canada). Immunoblotted substrates were visualized
using enhanced chemiluminescence (Pierce, Inc., Rockford, IL). Neg-
ligible amounts of these substrates were detected in red cells and non-
neutrophil lymphoid cells (amounts equivalent to their contamination
of neutrophil samples were blotted (data not shown)).
2.5. Fluorogenic substrate assays
A continuous £uorometric assay for caspase-3 using the substrate
Ac-DEVD-AMC (amino-4-methylcoumarin) was used as described
[6]. Reaction mixtures containing 100 WM Ac-DEVD-AMC and neu-
trophil cytosols were monitored continuously in a spectro£uorometer
at an excitation wavelength of 380 nm and emission wavelength of 460
nm at 25‡C.
2.6. Apoptosis reconstitution system
S3 HeLa nuclei were used in in vitro apoptosis reconstitution ex-
periments as described [24], with the following modi¢cations. S3 HeLa
cells were harvested by centrifugation, washed twice with PBS, once
with NB (10 mM PIPES pH 7.4, 10 mM KCl, 2 mM MgCl2, 1 mM
DTT, 10 WM cytochalasin B, plus protease inhibitors), and resus-
pended at 1U108 cells/ml in NB. After swelling on ice for 20 min,
cells were lysed using a Dounce homogenizer (20 strokes). Nuclei were
obtained by layering the homogenate over 30% sucrose in NB, cen-
trifuging at 800Ug for 10 min, washing the pellet once in NB, and
resuspending at 1U108 nuclei/ml. Nuclei were either used immediately
or stored at 370‡C in the following bu¡er: 10 mM PIPES pH 7.4, 80
mM KCl, 20 mM NaCl, 250 mM sucrose, 50% glycerol, 5 mM
EGTA, 1 mM DTT, 0.5 mM spermidine, 0.2 mM spermine, and
protease inhibitors. To perform the reconstitution experiments, 5 Wl
of S3 HeLa nuclei were combined with 140 Wg of cytosol, and the
reaction volume was made up to 50 Wl by adding bu¡er containing 10
mM HEPES/KOH pH 7.4, 50 mM NaCl, 2 mM MgCl2, 0.1 mM
CaCl2, 40 mM L-glycerophosphate, 1 mM dithiothreitol, 2 mM
ATP, 10 mM phosphocreatine, 50 Wg/ml creatine kinase and protease
inhibitors. Samples were incubated at 37‡C for 2 h in the presence or
absence of increasing concentrations of Ac-DEVD-CHO and Ac-
YVAD-CHO (Merck Research Laboratories, Rahway, NJ). Nuclei
were then immunoblotted for substrates as described above.
3. Results and discussion
Previous studies have demonstrated that PARP and DNA-
PK are absent from mature neutrophils, although these pro-
teins are present in the promyelocyte cell line, HL-60 [25,26].
To determine whether absence of caspase substrates is a gen-
eral feature of neutrophils, freshly isolated human neutrophils
or neutrophils incubated in vitro for 24 h were disrupted by
nitrogen cavitation, and separated into cytosolic and nuclear
fractions prior to immunoblotting. As a standard, we used
control and UVB-irradiated (apoptotic) HeLa cell lysates,
since the caspase substrates and their apoptotic fragments
have been previously de¢ned in these cells [8,27]. Neither
the intact forms of PARP, NuMA, U1-70kDa and DNA-
PKcs, nor their characteristic apoptotic fragments were
present in freshly isolated neutrophils (Fig. 1, top 3 panels,
lanes 3 and 5, and data not shown). In contrast, fodrin and
lamin B were present in freshly isolated neutrophils in
amounts equivalent to HeLa cells (Fig. 1, lower 2 panels,
lanes 3 and 5). While fodrin was cleaved upon aging to gen-
erate 150 and 120 kDa apoptotic fragments similar to those
found in apoptotic HeLa cells (Fig. 1, 4th panel), no frag-
ments of lamin B were detected (data not shown). However,
the biochemical amount of lamin B was decreased in both
irradiated HeLa cells and 24 h aged neutrophils (Fig. 1). In-
terestingly, HL-60 cells, which are promyelocytes that di¡er-
entiate into neutrophils in response to retinoic acid or DMSO
[28], possessed PARP [25] and all the other caspase substrates
in amounts comparable to HeLa cells (data not shown).
We have previously demonstrated that PARP, U1-70kDa,
and DNA-PKcs are cleaved during apoptosis with similar ki-
netics and at similar sites by proteases of the caspase-3 sub-
family [29]. To address whether the absence of these substrates
from freshly isolated, mature neutrophils might be caused by
premature activation of the caspase-3 family in these cells, we
examined the presence and activity of caspases in fresh and
aged neutrophils. Neutrophils were lysed by sonication, and
after removal of granules by centrifugation, supernatants were
immunoblotted with antibodies against precursors of cas-
pases-1, -3 and -7. The precursors of caspases-1, 3 and 7
were detected (Fig. 2, and data not shown); levels of cas-
pase-7 precursor were much lower than the other caspases
(data not shown). An enzymatic assay that quantitates the
cleavage of the £uorogenic peptide substrate Ac-DEVD-
AMC was used to measure caspase-3 activity on aging neu-
trophil lysates. Ac-DEVD-AMC cleavage activity increased in
a time-dependent manner from zero at 0 h to 3.2 U/mg at 24 h
(Fig. 2, lowest panel), which is similar to the increase in ac-
tivity seen in apoptotic HeLa cells (data not shown). This
activity was inhibited by Ac-DEVD-CHO (500 nM) but not
by Ac-YVAD-CHO (500 nM), con¢rming that the activity
was due to caspase-3 or a closely related homologue (data
not shown).
The caspases are all synthesized as inactive precursors
which are cleaved at Asp-X sites during apoptosis, generating
a large and small subunit which together constitute the active
protease [2,30]. Since the Ac-DEVD-AMC cleavage is medi-
ated by a protease with caspase-3-like inhibition characteris-
tics, we immunoblotted caspase-3 in aging neutrophils at 8 h
intervals, to address whether caspase-3 precursor processing
occurred during neutrophil aging. A time-dependent decrease
in the 32 kDa caspase-3 precursor was observed, with 85%
being lost by 24 h; in contrast, the amount of actin remained
constant (Fig. 2, middle and lower panels). Consistent with
other studies, the active p17 fragment of caspase-3 could not
be well visualized by immunoblotting with this antibody [31].
In all experiments, at least 45% of neutrophils aged in vitro
for 24 h displayed chromatin condensation and loss of nuclear
lobulation on Wright-Giemsa staining (data not shown), fea-
tures characteristic of apoptosis in neutrophils. Therefore,
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freshly isolated neutrophils (i) contain the caspase-3 precur-
sor; the amount of this decreases with aging and apoptosis,
and (ii) acquire Ac-DEVD-AMC cleavage activity with cas-
pase-3-like inhibition characteristics with aging.
To address the macromolecular speci¢city of the Ac-
DEVD-AMC cleavage activity in neutrophils, we studied the
cleavage of the nuclear substrates PARP, U1-70kDa, and
DNA-PKcs by incubating S3 HeLa cell nuclei (which have
all these substrates; Fig. 3, lane 1) with cytosols from freshly
isolated and aged human neutrophils (which lack these sub-
strates; Fig. 3, lanes 3 and 4). After incubating S3 HeLa
nuclei with neutrophil cytosol for 2 h, reactions were stopped
by addition of 2% SDS and boiling, and samples were immu-
noblotted. Fresh neutrophil cytosol failed to induce cleavage
of DNA-PKcs, PARP, or U1-70kDa in HeLa nuclei (Fig. 3,
lane 5). In contrast, after incubating with 24 h aged neutrophil
cytosol, these proteins were cleaved to yield fragments identi-
cal to those seen in apoptotic HeLa cells (compare Fig. 3,
lanes 2 and 6). To con¢rm that the proteolysis of DNA-
PKcs, U1-70kDa, and PARP was indeed mediated by a cas-
pase-3-like protease, rather than other protease activity gen-
erated in the aging neutrophil, we examined the inhibitory
e¡ects of Ac-DEVD-CHO and Ac-YVAD-CHO on substrate
cleavage by aged neutrophil cytosol. Ac-DEVD-CHO is a
potent inhibitor of caspase-3 (Ki = 0.35 nM) in contrast to
Ac-YVAD-CHO, which inhibits this enzyme only at high con-
centrations (Ki = 10 000 nM) [6,32]. Ac-DEVD-CHO was a
potent inhibitor of cleavage of DNA-PKcs, U1-70kDa, and
PARP by aged neutrophil cytosols (IC50 = 0.6^2 nM), while
Ac-YVAD-CHO was markedly less potent (IC50 = 20 000^
50 000 nM) (Fig. 3). Consequently, the inhibition pro¢le of
aged neutrophil cytosol is consistent with caspase-3, or a
closely related homologue, being responsible for cleavage of
substrates in proteolysis reconstitution system. The small
amount of caspase-7 present in fresh neutrophils makes it
likely that the majority of this cleavage activity is due to
caspase-3.
These studies demonstrate that the caspase substrates
PARP, NuMA, U1-70kDa and DNA-PKcs are not detectable
by immunoblotting of mature neutrophils, although they are
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Fig. 1. Several caspase substrates are absent in neutrophils. Lanes 1, 2: Total cell lysate from control or apoptotic HeLa cells was prepared as
described, and were electrophoresed and immunoblotted with antibodies against PARP, NuMA, U1-70kDa, fodrin, and lamin B. Lanes 3^6:
Freshly isolated neutrophils or neutrophils that had been aged in vitro for 24 h were separated into cytosolic and nuclear fractions as described
in Section 2. Equivalent cell numbers were loaded in all lanes. Similar results were obtained in three separate experiments. Neutrophils lack
PARP, NuMA, and U1-70kDa, but contain fodrin and lamin B in amounts similar to those found in equal numbers of HeLa cells.
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present in HL-60 neutrophil precursor cells. In contrast, ma-
ture neutrophils do contain intact lamin B and fodrin, which
is cleaved during apoptosis to generate signature apoptotic
fragments. The absence of several caspase substrates from
neutrophils is unrelated to caspase activity, since Ac-DEVD-
AMC cleavage activity is absent in freshly isolated cells, and is
generated only with neutrophil aging. The failure to detect
several homeostatic proteins in non-apoptotic neutrophils in-
dicates that cells can tolerate signi¢cant decreases in the func-
tions that these proteins serve without becoming apoptotic.
Interestingly, cells deprived of functional NuMA form micro-
nuclei that resemble the multilobed neutrophil nucleus, as well
as nuclei undergoing apoptosis, in which NuMA cleavage
occurs coincidently with apoptotic body formation [18]. We
propose that the multilobed neutrophil nucleus may re£ect the
pre-apoptotic loss of NuMA in these cells.
The absence of several caspase substrates from neutrophils
also provides insights into the potential functional relevance
of cleavage of these and other substrates during apoptosis of
di¡erent cells. While it has previously been proposed that
fragments generated by cleavage of caspase substrates might
have critical roles in generating the apoptotic phenotype, the
lack of fragments of PARP, DNA-PKcs, U1-70kDa and
NuMA in neutrophils undergoing apoptosis makes it less
likely that fragments of these molecules have a critical role
in the execution phase of apoptosis. This conclusion is sup-
ported by the previous observation that PARP-knockout
mice, which cannot generate fragments of this molecule,
have no defects in apoptosis [33]. Interestingly, neutrophil
apoptosis is characterized by activation of caspases and cleav-
age of fodrin, lamin B, and D4-GDI [34] ; these changes occur
concomitantly with typical internucleosomal cleavage of
DNA, and morphologic changes of apoptosis. Since the cleav-
age of these cytoskeletal and homeostatic substrates coincides
with the onset of apoptosis, the altered function of these pro-
teins (or the generated fragments) may play a critical role in
neutrophil apoptosis. In this regard, it is of interest that gel-
solin (which is present in neutrophils) has recently been dem-
onstrated to be cleaved by caspases during apoptosis, and that
the fragments generated appear to have pro-apoptotic proper-
ties [35].
It has been proposed that the critical end-point of the apop-
totic process is the rapid termination of independent life, cul-
minating in e⁄cient phagocytosis and degradation of the
corpse. Several studies suggest that proteolysis during apop-
tosis alters the function of several pathways to render the
surface of apoptotic cells identi¢able by phagocytes, and the
apoptotic cell powerless to resist these changes by crippling
homeostatic pathways [14,19,20,29,36,37]. In terminally di¡er-
entiated, post-mitotic cells like neutrophils, which have down-
regulated several pathways and the machinery for their ho-
meostasis, rendering the surface of cells pro-phagocytic (by
alteration of membrane skeletal structure) may be a critical
initiator of neutrophil clearance by macrophages. In this re-
gard, it is of interest that fodrin cleavage (which may occur
due to caspase [14^16,38] or calpain activity [39]) has been
linked with the redistribution of phosphatidylserine (PS)
from the inner to the outer surface of the plasma membrane
bilayer; both fodrin proteolysis and PS redistribution charac-
terize the early apoptotic state [14,36,40,41]. This exteriorized
PS appears to be one of the signals by which apoptotic neu-
trophils are recognized and cleared by phagocytic cells [36].
Previous studies have demonstrated that neutrophils from
mice expressing bcl-2 in the neutrophil lineage are e⁄ciently
cleared by phagocytic cells upon aging, although they do not
undergo apoptosis [42]. Since several proteases appear capable
of cleaving fodrin, and one of these may be active under non-
apoptotic circumstances, it would be of interest to determine
if fodrin is cleaved, and PS is exteriorized in aged neutrophils
from these bcl-2 transgenic mice.
There is accumulating evidence that apoptotic material con-
stitutes an important immunogen in systemic lupus erythema-
tosus (SLE), and that several caspase substrates (PARP, U1-
70kDa, DNA-PKcs, lamin B and NuMA) are targets of the
autoantibody response in SLE [8,23,27,29]. In the setting of
immune complex-initiated in£ammatory responses (character-
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Fig. 2. Aging neutrophils show progressive loss of caspase-3 precur-
sor (A and B) and increasing Ac-DEVD-AMC cleavage activity (C).
A, B: Equal protein amounts of freshly prepared neutrophils, or
neutrophils aged for 8, 16, or 24 h were immunoblotted with anti-
bodies to actin or caspase-3 precursor as described in Section 2.
Densitometric scanning of the data in (A) showed that the amount
of actin remained constant over 24 h, but the caspase-3 precursor
levels decreased to 17% of the zero time values (B, and data not
shown). C: Neutrophils extracts were incubated with 100 WM of the
£uorogenic substrate Ac-DEVD-AMC at 25‡C as described in Sec-
tion 2. The cleavage activity of neutrophil cytosol increased with
aging, and corresponded with the decreased caspase-3 precursor lev-
els. A,B,C: All experiments were repeated three times with identical
results. THP-1 cell cytosol was used as a reference standard for mi-
gration of the caspase-3 precursor.
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istic of the lupus £are), a large number of neutrophils are
recruited, and subsequently become apoptotic. This large
source of apoptotic material, while rich in nucleosomes, con-
tains few of the de¢ned caspase substrates, making neutro-
phils an unlikely source of antigen to drive the ongoing im-
mune response to these molecules in SLE.
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